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The accurate assignment of molecular roles in membrane traffic is frequently complicated by the lack of specific inhibitors
that can work on rapid time scales. Such inhibition schemes would potentially avoid the complications arising from either
compensatory gene expression or the complex downstream consequences of inhibition of an important protein over long
periods (>12 h). Here, we developed a novel chemical tool to disrupt clathrin function in living cells. We engineered a
cross-linkable form of clathrin by using an FK506-binding protein 12 (FKBP)-clathrin fusion protein that is specifically
oligomerized upon addition of the cell-permeant cross-linker FK1012-A. This approach interrupts the normal assemblydisassembly cycle of clathrin lattices and results in a specific, rapid, and reversible ⬃70% inhibition of clathrin function.
This approach should be applicable to a number of proteins that must go through an assembly-disassembly cycle for
normal function.

INTRODUCTION
Cell-permeable inhibitors that are selective for individual
proteins allow the direct investigation of cellular function of
the given protein in a particular pathway (Kapoor et al.,
2000; Holt et al., 2002; Straight et al., 2003). Such molecules
hold several advantages over genetic strategies for the disruption of protein function. Unlike genetic deletions, cellpermeable inhibitors can in principle act quickly and reversibly and therefore avoid many of the complicating features
of either adaptation to or compensation for inhibition over
long time scales. Although temperature-sensitive alleles
have often proven powerful in many systems, they are difficult to implement in most mammalian systems. With these
advantages in mind, we sought to develop a specific chemical inhibitor that would allow for acute disruption of clathrin in living cells.
One of the most important routes for endocytosis is the
shared pathway through clathrin-coated pits that is used for
a variety of ligand–receptor complexes. Clathrin-coated vesicles mediate internalization from the plasma membrane
and transport from the trans-Golgi network to endosomes
and has long been considered to represent the dominant
pathway for internalization of many cell surface proteins
(Kirchhausen, 2000b). A clear delineation of what fraction of
endocytosis of a given component occurs through a particular pathway has proven difficult. The earliest approaches
for interrupting clathrin function made use of very broad
physiological perturbations, such as cytoplasmic acidification, that almost certainly block many molecular functions
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(Larkin et al., 1983; Heuser, 1989; Heuser and Anderson,
1989). Although more directed molecular approaches implicate clathrin as a part of a major pathway for many cell
surface proteins, a majority of the studies supporting this
proposal used dominant negative mutational analysis directed to associated proteins and not clathrin itself (Benmerah et al., 1998; Nesterov et al., 1999). Dynamin is an
additional clathrin-associated protein that has received
much attention (Damke et al., 1994). Until recently, it was
assumed that the internalization of any receptor or protein
that was perturbed by compromising the function of dynamin was by definition a clathrin-mediated event. However, it has now become clear that dynamin seems to function in several nonclathrin-mediated forms of endocytosis as
well (Pelkmans et al., 2002; Verstreken et al., 2002).
Furthermore, studies that have attempted to directly perturb clathrin function through genetic ablation, expression
of dominant negative clathrin constructs, or injection of
anti-clathrin antibodies have generally only yielded partial
inhibition of endocytosis (Wehland et al., 1981; Payne and
Schekman, 1985; Doxsey et al., 1987; Lemmon and Jones,
1987; Ruscetti et al., 1994; Liu et al., 1995, 1998; Wettey et al.,
2002). Thus, it is not clear to what extent many cell surface
receptors rely solely upon clathrin for their entry into cells.
Here, we developed a technique to specifically disrupt
clathrin function in living mammalian cells with high specificity and tight temporal control. We adapted a technique
developed to use the highly specific interaction between a
variant of the immunosuppressant FK506 and its target,
FK506-binding protein 12 (FKBP) (Spencer et al., 1993).
FK506 exerts its immunosuppressant function by forming a
trimeric complex with FKBP and calcineurin, a serine/threonine phosphatase (Ho et al., 1996). FK1012-A, a synthetic
dimer of FK506 simultaneously binds two separate FKBP
molecules (Spencer et al., 1993). Here, we constructed a
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fusion protein between FKBP and clathrin light chain and
established stable cell lines expressing this protein with a
high degree of molecular replacement of the endogenous
clathrin light chain. We demonstrate the effectiveness of this
chemical inhibition strategy by using a variety of biophysical assays of clathrin dynamics. Parallel measurements of
the kinetics of transferrin receptor endocytosis show that a
substantial fraction of transferrin uptake occurs independently of clathrin function.
MATERIALS AND METHODS
DNA Manipulation
Oligonucleotide polymerase chain reaction was used to make EGFP-FKBP-LC.
Oligonucleotides and restriction enzymes were purchased from Invitrogen
(Carlsbad, CA). FKBP was amplified with overhanging BglII and EcoRI sites by
using primers with the following sequences: AGATCTATGGGCGTGCAGGTG
and GAATTCGAAGCTTGAGCTCGTTCCAGTTTTAGAAGCTC. LC was amplified with overhanging EcoRI and SalI sites by using primers with the following
sequences: GAATTCTGCAATGGCTGAGTTGGATCCATTT and GTCGACTCAATGCACCAGGGGCGCCTGCTT. Doubly digested and purified fragments
were subcloned into the BglII and SalI sites of pEGFP-C1 (BD Biosciences Clontech, Palo Alto, CA).

Antibodies
Clathrin heavy chain was detected using the monoclonal antibody X22 (Affinity Bioreagents, Golden, CO). Clathrin light chain molecules were detected
using the monoclonal antibody CON.1 (Covance, Berkeley, CA) that detects
both clathrin light chain A and B.

Transfection
Constructs were transfected by the LipofectAMINE method (Invitrogen).
Cells were analyzed 24 –36 h after transfection for transient transfections.
TRVb-EFL cells were generated by transfecting TRVb Chinese hamster ovary
(CHO) cells with two plasmids: a plasmid encoding human transferrin receptor and hygromycin resistance and a plasmid encoding our EGFPFKBP-LC construct and G418 resistance. After transfection, G418 and hygromycin were added to the culture medium. After a week of growth and
selection, colonies derived from individual cells were obtained. Cells were
subsequently assayed for transferrin uptake and expression of EGFP-FKBPLC.

Cell Culture
CHO cells used in this report are derived from TRVb CHO cells that do not
express any functional transferrin receptor. TRVb-1 cells stably express human transferrin receptor and were cultured in McCoy’s 5A medium containing 5% fetal bovine serum, penicillin-streptomycin (Invitrogen), 26 mM sodium bicarbonate, and 0.2 mg/ml G418 (Invitrogen). TRVb-EFL cells stably
express human transferrin receptor and EGFP-FKBP-LC and were cultured
with the same media used for TRVb-1 cells supplemented with 400 –500 U/ml
hygromycin (Calbiochem-Novabiochem, San Diego, CA).

Western Blot
Subconfluent cells were washed twice with 150 mM NaCl, 20 mM HEPES, 1
mM CaCl2, 5 mM KCl, 1 mM MgCl2, pH 7.2 (medium 2) and lysed with 2%
SDS, 50 mM Tris, 1 mM phenylmethylsulfonyl fluoride. Proteins were precipitated with trichloroacetic acid and resuspended in 3⫻ loading buffer.
Samples were boiled for 5 min and centrifuged for 10 min at room temperature. Protein samples were run on a 10% SDS-polyacrylamide gel and transferred to nitrocellulose filter paper. The nitrocellulose filter paper was incubated with 1% milk powder, Tween 20 (0.1%) and Tris (blocking solution) on
a tilting device and left overnight at room temperature. The filter paper was
incubated with primary antibody (1:1000) in blocking solution for 1 h, washed
three times for 10 min each in blocking solution, incubated with secondary
antibody (horseradish peroxidase coupled to polyclonal goat anti-mouse IgG)
(1:2000) in blocking solution for 1 h, and washed once in blocking solution
and twice in blocking solution without milk powder. Specific protein bands
were reacted with enhanced chemiluminescence for 1 min, and the reaction
product was visualized on autoradiographic film.

Cross-Linking and Reversal of Cross-Linking Techniques
All cross-linking reactions were performed in McCoy’s 5A medium supplemented with 26 mM sodium bicarbonate, 20 mM HEPES, pH 7.2 (McBB) with
50 nM FK1012-A for 2 h at 37°C. Examination of the time course to achieve
maximal inhibition with FK1012-A indicates that the complete impact of
cross-linking with respect to endocytosis can be achieved with ⬃30 min. All
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reversal of cross-linking reactions were performed in McBB with 10 M
FK506 for 2 h at 37°C after a cross-linking incubation as described above.

Immunolocalization of Antibodies
Cells grown on coverslip bottom dishes were fixed with 3.7% formaldehyde
for 10 min. Dishes were stained with primary antibody in 250 g/ml saponin
in phosphate-buffered saline with 1% bovine serum albumin (permeabilization buffer) for 1 h at room temperature. Cells were washed in permeabilization buffer for 15 min (three 5-min washes). Cells were subsequently stained
with a goat anti-mouse secondary antibody conjugated to Alexa-546 (Molecular Probes, Eugene, OR) at a 1:2000 dilution for 1 h and washed for 15 min
(three 5-min washes) and examined by fluorescence microscopy.

Fluorescence Recovery after Photobleaching
Regions of 16.7 ⫻ 16.7 m of the cell surface, near the bottom of the cell, were
selected for analysis by fluorescence recovery after photobleaching. Five
prebleach frames were acquired using confocal microscopy at a spatial sampling of 110 nm/pixel. Cells were illuminated with ⬃3 W (measured in the
back-aperture) of the 488-nm line of an argon ion laser that was rapidly
shuttered during all nondata-acquiring periods, by using acousto-optic or
electro-optic modulation. The central 4.4 ⫻ 4.4 m of each image area was
photobleached by continuous scanning for 10 s with ⬃180 W, which typically resulted in a 70% reduction in fluorescence levels. Images were collected
every 4 s for the next 140 s. All imaging was performed at 37°C. Fluorescence
recovery was quantified using custom-built imaging software. Fluorescence
was normalized by subtracting the level of fluorescence after bleaching from
the fluorescence values at all time points and subsequently dividing each by
the maximal fluorescence before bleaching occurred. For control and reversed
cross-linking conditions the entire photobleached region was used to determine fluorescence recovery because it is not possible to follow the same
puncta due to the movement of puncta during the course of the experiment.
For experiments that used ␤-methyl cyclodextrin, FK1012-A and/or Lat-A,
fluorescence recovery was determined for individual clathrin puncta within
the photobleached region.

Transferrin Internalization
Cells were incubated with 3 g/ml 125I-transferrin (Tf) in McBB for 2, 4, 6, 8,
or 10 min. After incubation at 37°C the plates were placed on ice and washed
twice with medium 2 at 4°C. The cells were incubated for 5 min at 4°C in 0.5M
NaCl, 0.5 M glacial acetic acid, pH 2.0, and washed with medium 2. The cells
were solubilized and radioactivity was measured. Each time point was performed in triplicate. A parallel plate was incubated in medium 2 with 3
g/ml 125I-Tf at 4°C for 2 h. The cells were washed six times with medium 2,
solubilized, and radioactivity was measured. In each case, nonspecific binding was measured with 200-fold excess of unlabeled Tf added with radiolabeled Tf. The average nonspecific radioactivity was subtracted from the other
values. The slope of a plot of the ratio of internal Tf to surface Tf (4°C binding)
versus time is the internalization rate constant.

LDL Internalization
Cells were incubated with 10 g/ml 1,1⬘-dioctadecyl-3,3,3⬘,3⬘-tetramethylindocarbocyanine-conjugated low-density lipoprotein (DiI-LDL) in McBB for 2,
4, 6, or 8 min. After incubation at 37°C, the plates were placed on ice and
washed twice with medium 2 at 4°C. The cells were incubated for 5 min at 4°C
in 0.2 M NaCl and 50 mM 2-(N-morpholino)ethanesulfonic acid, pH 5.0,
followed by two washes with medium 2. The cells were fixed in 3.7% formaldehyde in 1⫻ phosphate-buffered saline before imaging. Fluorescence microscopy was performed with a DMIRB inverted microscope (Leica Microsystems, Deerfield, IL), with a cooled charge-coupled device camera
(Princeton Instruments, Trenton, NJ). All images were collected with a 63 ⫻
1.25 numerical aperture oil immersion objective. Images were processed and
quantified using MetaMorph software (Universal Imaging, West Chester,
PA). TRVb-EFL cells were manually selected, the total DiI fluorescence intensity per cell was calculated, and the average fluorescence intensity per pixel
was determined by dividing the total intensity by the area of the cell measured in pixels. Background fluorescence values were obtained from cells that
were not incubated with DiI-LDL. The background fluorescence intensity per
pixel was subtracted from the experimental data. The slope of a plot of the
ratio of internal LDL to surface LDL (4°C binding) versus time is the internalization rate constant.

Transferrin Recycling
Cells were incubated with 3 g/ml 125I-Tf in McBB at 37°C for 3 h to achieve
steady-state occupancy of the transferrin receptors. The cells were washed
twice with medium 2, followed by a 2-min wash in 200 mM NaCl, 50 mM
2-(N-morpholino)ethanesulfonic acid, pH 5.0, and two additional washes
with medium 2. Cells were incubated with 3 g/ml unlabeled Tf and 100 M
desferroxamine in McBB (efflux medium) at 37°C. The efflux medium was
collected at 1, 3, 5, 7, 10, or 15 min, and the cells were solubilized. Each time
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point was performed in duplicate. Nonspecific binding was measured by
adding 200-fold excess of unlabeled Tf. The recycling rate constant is the slope
of the natural logarithm of the percentage of Tf remaining within the cells
versus time.

Nonspecific Membrane Uptake
Cells were washed with warmed medium 2 and placed at 37°C for 5 min.
Cells were incubated with 15 M FM4-64 (Molecular Probes) in warmed
medium 2 for 0, 2, 5, 10, or 15 min at 37°C. Immediately after the addition of
FM4-64 to the 0-min time point, the plates were placed on ice and washed
twice with medium 2 at 4°C. The cells were incubated with 2 mg/ml ␤-cyclodextrin sulfobutyl ether, 7 sodium salt (Advasep 7) (CyDex, Overland
Park, KS) in medium 2 for 2 min to remove noninternalized, membraneassociated FM4-64. This step was repeated three times. Subsequently, the cells
were washed twice with medium 2 and incubated with 2 mM EDTA in
medium 2 at 4°C for 10 min. Plates were scraped and the internalization of
FM4-64 was quantified using a spectrofluorometer.

Optical Measurements, Microscopy, and Analysis
Laser-scanning fluorescence images were acquired at a spatial sampling of
110 nm/pixel through a 40 ⫻ 1.3 numerical aperture Fluar objective (Carl
Zeiss, Oberkochen, Germany), by using a custom-built laser scanning microscope. The microscope objective was equipped with a custom-built objective
heater to maintain the specimen at 37°C. EGFP-FKBP-LC fluorescence emission was collected using a 498 –538 band-pass filter; Alexa Fluor 546 emission
was collected using a 550 long-pass filter. A stack of 25 confocal images
through the cells at 1-m intervals was obtained and compressed into a single
image using custom-built imaging software.

Total Internal Reflection Microscopy
Cells were plated on glass coverslips and viewed with an inverted microscope
(IX-70; Olympus America, Melville, NY) through a 1.45 numerical aperture
objective (60⫻; Olympus) equipped with a custom-built objective heater used
to maintain the specimen at 37°C. An argon ion laser was used to excite
enhanced green fluorescent protein (EGFP) in total internal reflection mode,
by steering the beam to the outer-edge of the microscope objective backaperture using a TIR illuminator (Olympus). The angle of illumination was
adjusted to provide an evanescent field depth of ⬃250 nm. Images were
projected onto a charge-coupled device camera (Roper Scientific, Trenton,
NY). Cells were imaged using MetaMorph (Universal Imaging, Downingtown, PA).
TRVb-EFL cells were grown on coverslips and were imaged 48 –72 h after
plating. The microscope was focused on a region of 4 –12 cells. Images were
taken every 4 s for 2 or 3 min. Images were subdivided into a 16-region grid
(2 ⫻ 2 m/region) and inspected manually for the appearance or disappearance of spots from the field of view. Two types of activity with respect to these
fluorescent spots were described: 1) stationary: visualized throughout the
duration of image collection even if they drifted to another region in the field
of view; and 2) membrane budding: the sum of events that were initially in
the field of view, but disappeared at a later frame and events that were not in
the field at the beginning of the image collection showed up at some point and
then disappeared before the end of the image collection.

membrane as well as in a larger intracellular region, likely
the trans-Golgi network (Figure 2A). Similar expression patterns were obtained when the fusion construct was transfected into HeLa and NIH 3T3 cells (our unpublished data).
Cells transfected with the EGFP-FKBP-LC (EFL) construct
exhibited normal levels of transferrin uptake, indicating that
the additional protein modules do not interfere with normal
clathrin light chain function (see below).
To be effective, this cross-linking approach requires extensive molecular replacement of clathrin light chain. As a
result, we sought cell lines that would express the EFL
construct preferentially over the endogenous clathrin light
chain molecules. The parent cell line we chose was a mutagenized CHO cell line, TRVb, which does not express any
endogenous transferrin receptor (McGraw et al., 1987). A
colony derived from a single clone stably expressing both
EFL and the human transferrin receptor was selected for
subsequent biochemical analysis.
Clathrin light chains have a molecular mass of 25–35 kDa
that reflect different isoforms (LCa and LCb) and splice
variants (Jackson et al., 1987; Kirchhausen et al., 1987). TRVb
cells and TRVb-1 cells, a derivative of TRVb cells that stably
express human transferrin receptor, express clathrin light
chain molecules at the expected molecular mass of approximately 30 kDa (Figure 1B). However, TRVb-EFL cells exhibit a weak signal at the typical molecular weight for clathrin light chains. In contrast, they possess a strong band at
approximately 70 kDa, corresponding to the predicted molecular mass of the fusion construct (Figure 1B). The fusion
construct is preferentially expressed 10-fold over the endogenous clathrin light chains in TRVb-EFL cells. Assuming
random integration into clathrin triskelia, virtually no triskelia in these cells could have only endogenous light chains
(Kirchhausen et al., 1983). Furthermore, every puncta identified via immunofluorescence against clathrin heavy chain
exhibited colocalization with an EGFP-FKBP-LC fluorescent
puncta (Figure 1, C and D).

RESULTS

Cross-Linking Clathrin Light Chains Clusters Entire
Triskelia
Incubation of TRVb-EFL cells with FK1012-A causes a dramatic redistribution of fluorescence: large intracellular regions of high fluorescence and a clearing of the diffuse
cytoplasmic fluorescence (Figure 2, A and B). However,
fluorescent puncta remain associated with the plasma membrane. In addition, incubation with FK506, which serves as a
monovalent competitor of FK1012-A, reverses the phenotypic effects of cross-linking (Figure 2C). We verified that
FK1012-A induced redistribution of both the EGFP-FKBP–
tagged clathrin light chain as well as the endogenous heavy
chain of clathrin by immunofluorescence (Figure 2, D and E).
The overlap of the fusion construct and clathrin heavy chain
is essentially perfect indicating that clathrin light chains
remain attached to triskelia after cross-linking (Figure 2F).

We developed a recombinant fusion protein to serve as a
target for reversible, chemical cross-linking. We reasoned
that because an enhanced green fluorescent protein (EGFP)clathrin light chain fusion construct permits functional clathrin-mediated endocytosis, a similar fusion construct might
permit an additional protein module (Gaidarov et al., 1999).
Specifically, we generated a fusion construct with three separate protein domains: EGFP, FKBP, and rat clathrin light
chain a (LC) (Figure 1A). When stably expressed in CHO
cells, EGFP fluorescence was localized to structures highly
reminiscent of clathrin-coated pits (Figure 2A) on the plasma

Cross-Linking Severely Blocks Triskelia Exchange
We photobleached membrane-associated, fluorescent
puncta and quantified fluorescence recovery after photobleaching (FRAP) to evaluate the ability of clathrin lattices to
exchange triskelia with the cytoplasmic pool. In FRAP experiments, fluorescent molecules are irreversibly photobleached by focusing a high-powered laser beam on the
target area. Previously, it was illustrated that fluorescence
recovers from photobleaching in cells that express green
fluorescent protein-clathrin (Wu et al., 2001). Accordingly, if
the application of FK1012-A locks lattices in a conformation

Electron Microscopy of “Unroofed” Cells
TRVb-EFL cells were grown on carbon-coated glass and unroofed by brief
exposure to an ultrasonic burst in 70 mM KCl, 30 mM HEPES buffer, pH 7.2,
5 mM MgCl2, and 3 mM EGTA. Immediately after the ultrasonic burst, the
cells were fixed in 2% formaldehyde freshly dissolved from paraformaldehyde into KHMgE medium for 30 min, and subsequently quenched for 10 min
with 50 mM lysine and 50 mM glycine in KHMgE. Samples were then
processed by quick-freezing, freeze-drying, platinum replication (Heuser,
2000).
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Figure 1. Cross-linkable form of clathrin. (A)
Design of the EGFP-FKBP-LC fusion construct
(top) and the presumed integration of this construct into triskelia. (B) EGFP-FKBP-LC is preferentially expressed relative to endogenous
clathrin light chain molecules in TRVb-EFL
cells. Equal amounts of protein were loaded in
each lane. (C) EGFP-FKBP-LC puncta (top) in
TRVb-EFL cells colocalize with immunofluorescence derived from clathrin heavy chain
puncta (bottom). Bar, 5 m. (D) Distribution of
the relative intensity of fluorescence derived
from EGFP-FKBP-LC (LC) or immunofluorescence against clathrin heavy chain (HC) indicates that all clathrin pits incorporate the EGFPFKBP-LC fusion construct (n ⫽ 8; 800 puncta
total).

incompatible with triskelia exchange, recovery from photobleaching should be greatly diminished. After photobleaching, control cells maximally recovered 63.6 ⫾ 3.0% of their

fluorescence (Figure 3, A and B). Additionally, cells incubated with ␤-methyl cyclodextrin, which blocks coated pit
dynamics, also recovered a large proportion of their fluores-

Figure 2. EGFP-FKBP-LC and its associated
triskelion can be reversibly clustered. (A)
Clathrin-associated structures are localized to
the plasma membrane and the trans-Golgi
network in TRVb-EFL cells. Bar, 10 m. (B)
FK1012-A (50 nM, 2 h) leads to a clearing of
cytoplasmic clathrin and the formation of
large intracellular aggregates of clathrin.
Clathrin puncta remain associated with the
plasma membrane after cross-linking. (C)
FK506 (10 M, 2 h) reverses FK1012-A–mediated cross-linking, as clathrin distributes in a
similar pattern to that of the control condition
(A). (D–F) After incubation with FK1012-A,
EGFP-FKBP-LC fluorescence (D) and indirect
immunofluorescence against clathrin heavy
chain (E) overlap almost perfectly (F).
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Figure 4. FK1012-A disrupts clathrin-coated pit structure. (A) Unroofed TRVb-EFL cells exhibit typical flat clathrin lattices (top) and
curved clathrin-coated pits (bottom). (B) FK1012-A (50 nM, 55 min)
alters the structure of clathrin lattices. The fundamental network
within flat lattices and curved pits is extremely deformed. Additional proteinaceous material, presumably clathrin triskelia from the
cytoplasm, seems to coat the cytoplasmic surface of the structures.

Figure 3. FK1012-A reduces fluorescence recovery from photobleaching. (A) Plasma membrane-associated clathrin-coated pits imaged before (top), immediately after (middle) and 140 s after photobleaching
(bottom).
Immediately
after
photobleaching
fluorescence was reduced to a level ⬃70% of the initial fluorescence
levels (middle). (B) Average time course of fluorescence recovery
after photobleaching. Cross-linking clathrin triskelia with FK1012-A
(50 nM, 2 h) reduces fluorescence recovery fourfold. The cholesterol
sequestering agent ␤-methyl cyclodextrin (10 mM, 30 min) inhibits
recovery by 25% (control TRVb-EFL cells, n ⫽ 12; TRVb-EFL cells ⫹
FK1012-A, n ⫽ 6; TRVb-EFL cells ⫹ ␤-methyl cyclodextrin, n ⫽ 6, p;
TRVb-EFL cells ⫹ FK1012-A followed by FK506, n ⫽ 6).

cence (47.6 ⫾ 2.6%), indicating that the exchange of triskelia
occurs even in the absence of membrane budding events
(Subtil et al., 1999). However, cells that were cross-linked
with FK1012-A had considerably diminished recovery
(14.5 ⫾ 2.0%) (Figure 3B). Thus, cross-linking significantly
disrupts triskelia exchange.
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To investigate lattice structure further, we visualized
clathrin-coated pits and vesicles at the plasma membrane of
unroofed cells (Heuser, 2000). Untreated TRVb-EFL cells
possess prototypical flat lattices and various stages of
curved, endocytosing clathrin-coated pits that are indistinguishable from cells that do not express our construct (Figure 4A). In contrast, after FK1012-A incubation the lattices
and pits seem to be structurally distorted as well as coated
with additional material that obscures their normal architecture (Figure 4B). The additional material may be triskelia
from the free cytoplasmic pool of clathrin (Goud et al., 1985).
If precise interactions within the lattices and pits are fundamentally important to clathrin function, the cross-linked
state may have a significantly perturbed ability to undergo
endocytosis.
Cross-Linking Reduces the Frequency of Membrane
Budding
For a precise account of clathrin dynamics at the cell surface,
we used total internal reflection-fluorescence microscopy
(TIR-FM). TIR-FM sets up a shallow, evanescent field of
illumination within several hundred nanometers of the interface enabling the excitation of fluorescent molecules located preferentially near the plasma membrane. This technique eliminates much of the out-of-focus fluorescence that
hinders wide-field fluorescence microscopy and allows one
to characterize the dynamics of clathrin budding from and
appearance at the cell surface (Steyer and Almers, 2001). The
disappearance of a clathrin puncta from the cell surface as
observed in this manner is tightly correlated with dynamin
recruitment (Merrifield et al., 2002).
An example of a putative budding event as viewed in
TIR-FM is shown in Figure 5A, indicated by the arrow.
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Figure 5. FK1012-A reduces membrane budding of clathrin-coated
pits. (A) Time-lapse images of membrane budding at the cell surface
were acquired with total internal reflection fluorescence microscopy. The budding activity of each clathrin-coated pit in the field of
view was documented. The arrow indicates a clathrin-coated pit
leaving the field of view in successive frames. (B) A large percentage
of clathrin-coated pits in untreated TRVb-EFL cells undergo a membrane budding event. FK1012-A (50 nM, 2 h) reduces the number of
membrane budding events and increases the number of stationary
coated pits. Subsequent application of FK506 (10 M, 2 h) returns
the number of membrane budding events to that of the control
condition. (Control, n ⫽ 18; FK1012-A, n ⫽ 12; FK1012-A followed
by FK506, n ⫽ 6).

During this 12-s episode, a fluorescent spot that likely
corresponds to an assembled clathrin lattice disappears
from the field of view, whereas neighboring spots remain.
Consistent with previous reports, in untreated conditions,
the majority of clathrin puncta underwent dynamic movements either appearing at or disappearing from the cell
surface, whereas the remainder underwent only lateral
movements (Gaidarov et al., 1999; Merrifield et al., 2002).
To estimate the number of dynamic events that would
most likely be related to coated pit budding from the cell
surface, we counted the number of puncta that disappeared during a fixed recording period. This included
events where the clathrin spots were present at time 0 in
a manner similar to that shown in Figure 5A as well as
those where the clathrin puncta appeared and subsequently disappeared. To minimize possible contamination
with clathrin-mediated membrane traffic originating at
the trans-Golgi network, we chose areas that were not
directly underneath the perinuclear region.
We presumed that cross-linking triskelia would lock
clathrin-coated pits on the membrane or into structures that
are incompatible with membrane budding. Indeed, after
FK1012-A treatment the total number of putative budding
events was reduced by ⬃70% (Figure 5B). After reversal of
cross-linking with FK506, the number of putative budding
events returned to the original control baseline levels.
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Cross-Linking Inhibits Endocytosis of Transferrin and
LDL
Because cross-linking imposes a significant inhibition of
clathrin dynamics, we addressed whether cross-linking also
inhibited the uptake of transferrin via the transferrin receptor. There is considerable evidence indicating that transferrin internalization is dependent on clathrin function. It
has been proposed that transferrin receptors are recruited to
a clathrin-coated pit, internalized, and transported to endosomal compartments (Dautry-Varsat et al., 1983). Thus, disrupting clathrin function would likely perturb transferrin
uptake.
TRVb-EFL cells internalize transferrin with a rate constant
of 0.174 ⫾ 0.01/min (Figure 6A), similar to TRVb-1 cells,
suggesting the addition of EGFP-FKBP to the clathrin light
chain does not perturb clathrin function. In contrast, when
cells are incubated with FK1012-A, the internalization rate
constant decreases by 55%, to 0.079 ⫾ 0.054/min. Importantly, samples cross-linked with FK1012-A and subsequently incubated with a large molar excess of FK506, internalized transferrin with a rate constant similar to control
conditions (0.147 ⫾ 0.09/min). Furthermore, FK1012-A had
no effect on transferrin uptake in TRVb-1 cells (Figure 6A).
FK1012-A also reduces the rate constant of LDL uptake by
⬃50% (from 0.061 ⫾ 0.007/min in untreated cells to 0.033 ⫾
0.008/min after FK1012-A) (Figure 6B). For most experiments, FK1012-A was applied for 2 h; however maximal
inhibition of transferrin uptake is achieved in ⬃30 min (our
unpublished data). To verify that FK1012-A inhibits transferrin internalization in all cells we examined, rather than
complete inhibition in a subset of cells, we analyzed uptake
in individual TRVb-EFL cells. At the single cell level, across
the entire population of TRVb-EFL cells, FK1012-A decreases the internalization rate of Cy3-transferrin to the
same level as indicated by iodinated transferrin uptake indicated above (our unpublished data).
Once internalized, the return of transferrin receptor to the
cell surface (efflux) was largely insensitive to clathrin crosslinking (Figure 6C), consistent with the notion that clathrin
does not play a role in trafficking molecules from the endosome back to the plasma membrane (Kirchhausen, 2000a).
Because intracellular trafficking is a dynamic process, involving an intricate interplay between endocytosis and exocytosis, a block of endocytosis without a concomitant decrease in exocytosis would result in an accumulation of
transferrin receptor on the surface of the cell. In fact, there is
a 61 ⫾ 1.1% increase in the fraction of transferrin receptor on
the surface (Figure 6D). In contrast, reversal of the crosslinking returns the surface fraction to a level comparable
with the control condition (an increase of only 14.1 ⫾ 3.1%
relative to control) (Figure 6D). In addition, there was no
effect of FK1012-A on the surface fraction in TRVb-1 cells
(Figure 6D).
An alternative mechanism of uptake is nonspecific membrane uptake. Nonspecific uptake refers to the internalization of molecules independent of a specific association with
a receptor. Thus, we have looked at the uptake of FM4-64, an
amphipathic dye whose quantum yield increases substantially when it is localized in a membrane. There is no evidence to suggest that FM4-64 is preferentially recruited to
specific areas of the membrane (our unpublished data). Accordingly, if the mechanism of transferrin uptake in the
absence of normal clathrin function is an increase in nonspecific membrane uptake, there should be increased uptake
of FM4-64 in these cells. However, cross-linked cells show
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Figure 6. Cross-linking of triskelia perturbs membrane traffic in TRVb-EFL cells. (A) TRVb-EFL cells internalize transferrin at a similar rate to that of
TRVb-1 cells. FK1012-A (50 nM, 2 h) reduces the rate of internalization of transferrin by ⬃50% in TRVb-EFL cells but fails to inhibit internalization in
TRVb-1 cells. Application of FK506 (10 M, 2 h) to TRVb-EFL cells returns the rate of internalization of transferrin to control levels in previously
cross-linked cells. The data are the averages of three separate experiments under identical conditions ⫾ SE. (B) FK1012-A (50 nM, 2 h) reduces the LDL
internalization rate constant by ⬃50% compared with control TRVb-EFL cells. The data represent the average internalization values of LDL in ⬎80
TRVb-EFL cells per data point. (C) Transferrin recycling is minimally perturbed in cross-linked TRVb-EFL cells. The graph represents the averages of three
separate experiments under identical conditions ⫾ SE. (D) FK1012-A (50 nM, 2 h) increases the steady-state surface levels of transferrin receptor. The data
are the average of three separate experiments under identical conditions ⫾ SE. (E) Internalization of FM4-64 is unaffected by FK1012-A (50 nM, 2 h) in
TRVb-EFL cells. The data are the average of three separate experiments under identical conditions ⫾ SE.
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an almost identical internalization time course compared
with control cells (Figure 6E). Thus, over the time scales of
these experiments it does not seem that the cell has generated a bulk membrane uptake compensatory response.
Latrunculin-A (Lat-A) Alters Clathrin Dynamics
To clarify the molecular mechanisms responsible for the
residual ⬃50% of uptake in the cross-linked state, we
searched for alternative molecular targets. Many reports
have indicated a potential role for various components of the
cytoskeleton in endocytosis. In particular, actin has a vital
role in endocytosis in Saccharomyces cerevisiae (Munn, 2001;
Schafer, 2002). Although actin’s role in mammalian cells is
debated, inhibition of actin can reduce receptor-mediated
endocytosis by ⬃50% in some cells (Lamaze et al., 1997;
Fujimoto et al., 2000).
To assess actin’s role in clathrin-dependent endocytosis,
we used Lat-A, an actin-monomer-sequestering agent. FRAP
analysis of the extent of exchange of triskelia with assembled
clathrin lattices indicated that Lat-A reduced the size of the
exchangeable pool by approximately twofold (Figure 7A).
Analysis of membrane budding as described in Figure 5
indicated that actin disruption also decreases the frequency
of membrane-budding events by ⬃40% (Figure 7B).
Given the alteration in clathrin-coated pit budding, we
assayed whether Lat-A would alter transferrin uptake. Similar to the FK1012-A–mediated decrease in transferrin uptake, Lat-A reduced the rate of transferrin uptake by ⬃50%
(from 0.177 ⫾ 0.029/min for the controls to 0.081 ⫾ 0.003/
min after Lat-A treatment) (Figure 7D). The reduced rate of
internalization was accompanied by an increase in the
steady-state surface fraction of transferrin receptor (63.0 ⫾
8.1% more than the control) (Figure 7E). Preincubation of
cells with Lat-A did not alter FM 4-64 uptake in TRVb-EFL
cells relative to control conditions (our unpublished data).
FK1012-A–Mediated Cross-Linking and Latrunculin-A
Together Completely Block Clathrin Dynamics at the Cell
Surface
Given the significant effect of FK1012-A and Lat-A alone, we
tested whether together they would have a more pronounced effect. Cells whose clathrin was cross-linked with
FK1012-A and then incubated with Lat-A, showed a further
reduced fluorescence recovery after photobleaching to only
3.9 ⫾ 1.1% of prebleach levels (Figure 7A). Moreover, clathrin-mediated vesicular budding was completely blocked,
because there were almost no spots that disappeared during
recording periods after coincubation (Figure 7C). Furthermore, the internalization rate of transferrin in cells incubated
with FK1012-A and Lat-A was reduced by 80% to 0.035 ⫾
0.002/min (Figure 7D). Similarly, coincubation increased the
steady-state surface fraction of transferrin receptor to
213.7 ⫾ 4.2% of control cells (Figure 7E).

In addition, the results provided clearly indicate a substantial role for actin in clathrin-dependent endocytosis.
Several clathrin-deficient genetic organisms are capable of
growth, division, and other essential homeostatic processes
(Payne and Schekman, 1985; Lemmon and Jones, 1987; Ruscetti et al., 1994). Furthermore, a mammalian cell line has
been generated that can completely repress clathrin expression within several days (Wettey et al., 2002). In contrast, our
technique presents a novel opportunity to address clathrin
function through rapid chemical cross-linking in mammalian cells. Our investigation indicates that clathrin-dependent processes, such as transferrin uptake, still occur when
clathrin function is severely limited due to cross-linking.
Moreover, the residual function of clathrin-dependent processes is completely blocked upon the elimination of actin
function.
Of note, clathrin remains on the plasma membrane and
there is a notable aggregation of fluorescence inside the cell
after cross-linking (Figure 2). Although the molecular composition of these aggregates remains unknown, these aggregates may be clathrin-coated vesicles and/or the soluble
pool of clathrin triskelia. Alternatively, the apparent aggregation may involve the recruitment of these constituents to
the trans-Golgi network. Interestingly, the membrane-associated clathrin shows a dramatic reduction in the ability to
exchange with the free cellular pool of triskelia (Figure 3). In
contrast to previous reports, we did not witness complete
recovery from photobleaching in control conditions (Wu et
al., 2001). However, it is possible that TRVb-EFL cells have a
larger percentage of triskelia in clathrin-coated pits that do
not exchange, and therefore, fail to show a complete recovery from photobleaching. Furthermore, the cross-linked
clathrin has a dramatically reduced ability to bud from the
surface (Figure 5).
The fact that Lat-A and FK1012-A separately reduce the
rate of transferrin uptake by 50% and together give an
additive effect of 80% raises an important question: Are
these separate pathways or separate parts of the same pathway? Because Lat-A further inhibits clathrin function, as
assessed with fluorescence recovery from photobleaching of
membrane-associated clathrin and total internal reflection
microscopy of clathrin-coated pit budding, it is apparent
that the Lat-A–mediated reduction in transferrin uptake occurs through a clathrin-dependent pathway. However, at
the present time is not possible to determine the roles of
clathrin and actin more precisely in endocytosis.
Recently, several reports have identified clathrin-independent pathways of internalization. Little documentation exists for the uptake of “clathrin-dependent ligands” through
nonclathrin pathways. One can estimate the size of the clathrin-independent pathway compared with the clathrin pathway in the following manner. If one assumes that the total
rate of transferrin uptake is governed by the rate kT and is
the result of two independent pathways, then

DISCUSSION
In this report, we investigated the contribution of clathrinmediated uptake in cells by creating clathrin that is susceptible to specific and acute chemical inhibition. TRVb-EFL
cells are viable and seem to behave normally. TRVb-EFL
cells provide us with an experimental model to study clathrin dynamics as well as transport processes regulated by
clathrin function by enabling us to reversibly inhibit clathrin
function on a rapid time scale. This study also provides a
quantification of clathrin-coated pit dynamics in living cells.
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kT ⫽ kclat ⫹ kother

(1)

where kclat is the rate constant for the clathrin-dependent
pathway and kother that for all other pathways. In the presence of FK1012-A, the frequency of membrane budding
events decreases on average by 3.3-fold and the internalization of transferrin decreases by 2.2-fold. Thus,
kTFK ⫽ kT/2.2

(2)

whereas
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Figure 7. Inhibition of actin in TRVb-EFL cells inhibits clathrin-dependent endocytosis. (A) Lat-A (10 M, 30 min) weakly inhibits fluorescence recovery
after photobleaching. However, when Lat-A is combined with FK1012-A (50 nM, 2 h), recovery of fluorescence is completely inhibited (control TRVb-EFL
cells, n ⫽ 12; TRVb-EFL cells ⫹ Lat-A, n ⫽ 6; TRVb-EFL cells ⫹ FK1012-A, n ⫽ 6; TRVb-EFL cells ⫹ FK1012-A followed by Lat-A, n ⫽ 6). (B) Lat-A (10
M, 30 min) reduces membrane budding events and increases the number of stationary coated pits as viewed with TIR-FM (control, n ⫽ 18; Lat-A, n ⫽
6). (C) The combined effect of FK1012-A (50 nM, 2 h) and Lat-A (10 M, 30 min) is a complete abolishment of membrane budding (control, n ⫽ 18;
FK1012-A, n ⫽ 12; FK1012-A ⫹ Lat-A, n ⫽ 6). (D) FK1012-A (50 nM, 2 h) and Lat-A (10 M, 30 min) each reduce the transferrin internalization rate constant
to ⬃50% of the rate of untreated control TRVb-EFL cells. TRVb-EFL cells incubated with FK1012-A (50 nM, 2 h) followed by Lat-A (10 M, 30 min) reduces
the transferrin internalization rate constant to 20% of the rate of control cells. The data are the average of three separate experiments under identical
conditions ⫾ SE. (E) Incubation of TRVb-EFL cells either with Lat-A, FK1012-A, or FK1012-A followed by Lat-A significantly increases the steady-state
levels of transferrin receptor on the surface of TRVb-EFL cells. The data are the average of three separate experiments under identical conditions ⫾ SE.
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kclatFK ⫽ kclat/3.3.

(3)

Assuming that FK1012-A has no effect on kother, then
kTFK ⫽ kclat/3.3 ⫹ kother

(4)

Combining these equations indicates that kclat ⫽ 3.6 kother;
thus, the clathrin-independent pathway represents ⬃22% of
the total uptake pathway of transferrin in these cells. Because this is in close agreement with the rate of transferrin
internalization measured in the absence of any clathrinrelated membrane budding (⬃20% of control using
FK1012-A and Lat-A), we conclude that the clathrin-independent pathway is not inhibited by Lat-A. In TRVb-EFL
cells, the combined activity of FK1012-A and Lat-A eliminates clathrin dynamics. Thus, a substantial portion of transferrin can enter cells through a nonclathrin, Lat-A-insensitive pathway. The lack of sensitivity to Lat-A in the residual
pathway, argues against a role in the pathways described
recently that implicate cdc42 or rhoA, although it is possible
that this process is refractory to Lat-A (Lamaze et al., 2001;
Sabharanjak et al., 2002).
Our results suggest a role for actin in clathrin-dependent
processes in mammalian cells. Studies in S. cerevisiae led to
the identification of many cellular components required for
endocytosis. Early studies indicated that actin serves a fundamentally important role in endocytosis, whereas clathrin’s
role is more ambiguous. Additionally, many of the requirements for endocytosis seemed to differ in higher eukaryotes.
However, many of the proteins involved in endocytosis in
yeast have subsequently been ascribed roles in similar pathways in higher eukaryotes (Schafer, 2002). Of note, a recently described protein family, consisting of the yeast protein Sla2p and the mammalian Huntingtin-interacting
protein-1 and Huntingtin-interacting protein-1-related may
link clathrin to the actin cytoskeleton (Engqvist-Goldstein et
al., 1999, 2001).
Recently, chemical genetic and targeted chemical inhibition schemes have proven valuable tools in assessing the
physiological roles of proteins through acute chemical control (Kapoor et al., 2000; Holt et al., 2002). Using a homodimerization scheme, we show that it is possible to design a potent inhibitor of a protein whose function is
normally accompanied by a cycle of assembly and disassembly. This reversible cross-linking tool may thus be useful in
the targeted inactivation of other trafficking proteins whose
function also critically depends on such assembly-disassembly cycles.
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